Expertise in
2
conditions

Daniel M. Forton

St George's University Of London
London, ENG, GB 
Expertise in
2
conditions
St George's University Of London
London, ENG, GB 

Overview

Daniel Forton practices practicing medicine in London, United Kingdom.

Mr. Forton is highly rated in 2 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis C, Hepatitis B, and Cirrhosis.

He is actively involved in clinical research, co-authoring 35 peer reviewed articles and participating in 4 clinical trials.

Gender

Male

Locations

St George's University of London
London, ENG, United Kingdom

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Phase I, Randomized, Double-blind, Placebo-controlled, Multi-centre, Ascending-dose Trial to Evaluate the Safety, Tolerability and Immunogenicity of Vaccine FP-02.2 in HBeAg-negative Hepatitis B Patients as an add-on Treatment to Entecavir or Tenofovir.
A Phase I, Randomized, Double-blind, Placebo-controlled, Multi-centre, Ascending-dose Trial to Evaluate the Safety, Tolerability and Immunogenicity of Vaccine FP-02.2 in HBeAg-negative Hepatitis B Patients as an add-on Treatment to Entecavir or Tenofovir.
Enrollment Status: Completed
Publish Date: May 22, 2025
Intervention Type: Other, Biological
Study Phase: Phase 1
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
A Randomized, Double-Blind, Placebo-Controlled Phase 2 Study Comparing the Efficacy and Safety of Tirzepatide Versus Placebo in Patients With Nonalcoholic Steatohepatitis (NASH)
Enrollment Status: Completed
Publish Date: January 24, 2025
Intervention Type: Drug
Study Drug: Tirzepatide
Study Phase: Phase 2
Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)
Non-invasive Rapid Assessment of Non-alcoholic Fatty Liver Disease (NAFLD) Using Magnetic Resonance Imaging With LiverMultiScan (RADIcAL1)
Enrollment Status: Completed
Publish Date: August 22, 2023
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated Interferon and Ribavirin
Telaprevir in Patients With Genotype 3 HCV: Pilot Clinical Study to Evaluate Efficacy and Predictability of Therapy in Patients Who Have Failed to Respond to Pegylated Interferon and Ribavirin
Enrollment Status: Completed
Publish Date: January 05, 2023
Intervention Type: Drug
Study Drugs: Telaprevir, 40 Kd Pegylated interferon alfa 2a, Ribavirin
Study Phase: Phase 4
View 3 Less Clinical Trials

35 Total Publications

Characterising Hepatitis D Virus in the UK From 2011 to 2021.
Characterising Hepatitis D Virus in the UK From 2011 to 2021.
Journal: Journal of viral hepatitis
Published: March 20, 2026

Frequently Asked Questions about Daniel M. Forton

Is Daniel M. Forton a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Daniel M. Forton is classified as an Advanced expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Daniel M. Forton participate in research or clinical trials?

Yes. Daniel M. Forton has published 35 articles and abstracts on conditions like Hepatitis. You can view a list of Daniel M. Forton's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Forton's expertise for a condition
ConditionClose
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile